| AFCLX | CEUAX | AFCLX / CEUAX | |
| Total Expense Ratio | 1.35 | 0.86 | 157% |
| Annual Report Gross Expense Ratio | 1.35 | 0.86 | 157% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 3.638 | 6.922 | 53% |
| Front Load | 6% | 4% | 164% |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 209M | 143B | 0% |
| Annual Yield % from dividends | 0.00 | 2.51 | - |
| Returns for 1 year | 8.94 | 13.90 | 64% |
| Returns for 3 years | 24.38 | 26.50 | 92% |
| Returns for 5 years | -4.01 | -1.33 | 302% |
| Returns for 10 years | 103.93 | 70.09 | 148% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 47.73 | 2.26 | +4.97% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| PDP | 153.18 | 2.30 | +1.52% |
| Invesco Dorsey Wright Momentum ETF | |||
| TDV | 104.45 | 0.35 | +0.34% |
| ProShares S&PTech Div Arstcrts ETF | |||
| DHDG | 36.42 | -0.02 | -0.04% |
| FT Vest U.S. Eq Qt 2.5 to 15 Buffr ETF | |||
| XYZY | 24.98 | -0.48 | -1.87% |
| YieldMax XYZ Option Income Strategy ETF | |||